000 01469 a2200349 4500
005 20250518100128.0
264 0 _c20210427
008 202104s 0 0 eng d
022 _a1815-7920
024 7 _a10.5588/ijtld.19.0409
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMasuku, S D
245 0 0 _aManaging multidrug-resistant tuberculosis in South Africa: a budget impact analysis.
_h[electronic resource]
260 _bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
_c04 2020
300 _a376-382 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAntitubercular Agents
_xtherapeutic use
650 0 4 _aCost-Benefit Analysis
650 0 4 _aHealth Care Costs
650 0 4 _aHumans
650 0 4 _aSouth Africa
650 0 4 _aTuberculosis, Multidrug-Resistant
_xdrug therapy
700 1 _aBerhanu, R
700 1 _aVan Rensburg, C
700 1 _aNdjeka, N
700 1 _aRosen, S
700 1 _aLong, L
700 1 _aEvans, D
700 1 _aNichols, B E
773 0 _tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
_gvol. 24
_gno. 4
_gp. 376-382
856 4 0 _uhttps://doi.org/10.5588/ijtld.19.0409
_zAvailable from publisher's website
999 _c30883493
_d30883493